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Magnetic resonance imaging (MRI) can also be used to follow the kinetics of the boron compounds. [15] [16] [17] [18] [19] [20] It is indeed a noninvasive tool, and contrast can be modified by the injection of extrinsic contrast agents. Although boron-11 MRI has been studied for this purpose, [15] [16] [17] [18] the actual nucleus for neutron capture reaction is boron-10, and therefore the administration of extra amounts of boron-11 compound (which does not undergo the nucleic reaction) is needed for MR imaging. A gadolinium-DTPA complex 1, which is commercially available under the trade name of "Magnevist" and is used as an MR imaging contrast medium, is paramagnetic; therefore, its effect on the contrast of the images can best be seen on T 1 -weighted images with short repetition times. The effect is caused by the gadolinium ion in the center, which induces an enhancement of T 1 relaxation. It has been observed that the blood-brain barrier of a brain tumor is disrupted, and that the complex 1 can pass through this disrupted barrier and enter into the tumor tissue. [21] [22] [23] [24] [25] Furthermore, gadolinium-157 has a higher thermal neutron capture cross section (255000 b) in comparison with that of boron-10 (3838 b). It occurred to us that a combination of gadolinium-157 and boron-10 might prove effective not only as an MR imaging but also as a neutron capture therapy. 26) We have recently succeeded in the synthesis of the gadolinium-DTPA complex 2 which contains a carborane unit attached via a palladium catalyzed C-C bond formation reaction. 27, 28) Herein we report in vivo evaluation of the complex 2 in tumor-bearing rats using MRI, ICP, and a-autoradiographic methods. Figure 1a shows the sagittal T 1 -weighted MR image of a rat with a tumor implanted on its back before injection of any compounds, and Figs. 1b-d show the images at 4 min 23 s (b), 11 min 32 s (c), and 50 min 54 s (d) after injection of compound 2. The signal intensity of kidney, liver, bladder, heart, and tumor on the images is calculated by Philips software and the intensity of the images versus time is plotted in Figs. 2a and 2b. The signal intensity is plotted as the ordinate and the time after injection is plotted on the horizontal axis. Although the dynamic change of the intensity in each tissue can be seen from these images, comparison of the intensity among the tissues is not possible since the signal intensity strongly depends on the distance between the tissue and the surface coil.
Results

MR Imaging of Rat Tumor with Gd-Carborane Complex 2
A contrast enhancement was observed in the center of the tissue, which is indicated by the circle in Figs. 1c (Fig. 2b) . The signal intensity of kidney rapidly increased after injection of the compound and remained constant throughout the experimental period, whereas that of liver, heart, and tumor rapidly increased after injection and then slowly decreased (Fig. 2) . Further, the contrast enhancement was also observed in the bladder at 50 min after injection, which is indicated by the arrow in Fig. 1d . The signal intensity of the bladder increased at 45 min after injection (Fig.  2a) . On the other hand, the signal intensity of all tissues increased rapidly after injection of normal Gd-DTPA 1 and decreased rapidly after 10 min (Fig. 3) . The signal intensity of bladder also increased rapidly after injection.
Gadolinium Concentrations in Various Tissues of Rats with Gd-Carborane Complex 2 Using ICP-AES Method
The distribution of gadolinium in the body of rats is shown in Fig. 4 . The concentration of gadolinium (ppm) in 100 mg of tissue is plotted as the ordinate and the time after injection is plotted on the horizontal axis. The gadolinium concentration in blood was 9.1 ppm at 5 min after injection and then decreased very rapidly. The concentrations in kidney and liver increased after injection, reached a maximum value at 20 min and then decreased. However, the concentration of gadolinium in tumor and brain was very low.
Boron Distribution in the Body of Tumor-Bearing Rats Visualized by a a-Autoradiography The a-autoradiography of the rats bearing tumor is shown in Fig. 5 . The boron was mainly distributed in the blood pool and the concentration was relatively high in heart, lung, and kidney at 15 min after injection (Fig. 5a) . However, the concentration of boron in the blood decreased whereas it was still high in the intestines and kidney at 60 min after injection (Fig. 5b) . Although the boron concentration in the tumor was relatively low at 15 min, higher accumulation of boron was visualized in the center of the tumor tissue and in the intestines at 60 min.
Discussion
It is important to learn whether gadolinium complex is stable in the body or if gadolinium is dissociated from the boronated DTPA scaffold. We tried to determine the boron concentrations in various tissues of rats. However, it was difficult to measure them by ICP-AES since unidentified strong signals and the boron signals overlapped each other, which made it difficult to observe precise and correct boron concentration. Nevertheless, ever under these difficult conditions, we determined the boron concentrations in the brain tissue as 17 ppm at 20 min and 12 ppm at 60 min. The gadolinium concentration, however, was too low to be detected. There are two possible explanations for this strange observation. First, gadolinium was dissociated from the boronated DTPA scaffold in the body and only boron was incorporated in the tissue. Second, the values of boron concentration were wrong and perhaps no boron was present in the tissue. The experiment using a-autoradiography clearly indicates that the second possibility is correct and that boron is not accumulated in the brain portion (see Fig. 5 ). The data of the boron concentration obtained from the ICP-AES experiment are therefore not reliable, and only the gadolinium concentration determined by this experiment is discussed in this paper.
The visible contrast enhancement effected by compound 2 was obtained from the MR imaging experiment. Compound 2 is distributed in the necrotic inner part of tumor tissue (Figs. 1c-d and 2b) . The same tendency is observed in Fig.  5 , although low uptake into the tumor tissue is observed in Fig. 4 . These different observations reflect which part of the tissue is measured. Actually, the outer part (not the necrotic part) of tumor tissue was removed and used for the ICP-AES experiment; thus, low gadolinium concentration is obtained in tumor tissue in Fig. 4 . The outside of the necrotic part of tumor is not visualized by the a-autoradiography in Fig. 5 , which supports the results obtained from the ICP-AES experiment. The tumor/blood ratio of the compound is very low (0.075 at 20 min after injection in Fig. 4 ) and the higher ratio is required for boron carriers (for example, the tumor/blood ratio of BSH, which is clinically utilized for brain tumor, is ca. 1). 7) Compound 2 is also incorporated into kidney and liver and excreted gradually (Figs. 2 and 4) , whereas Gd-DTPA 1 is excreted rapidly from the body (Fig. 3) . The lipophilic functional group, carborane, attached to the molecule is believed to make the gadolinium-DTPA complex remain longer in the tissues. The intestines are visualized at 60 min in Fig. 5 , which indicates that compound 2 is also metabolized via the liver and excreted in the bile.
Conclusion
Carborane containing Gd-DTPA 2 has been synthesized as a dual labeled probe for MR imaging and neutron capture therapy. It is clear from the MRI experiment that compound 2 is effective for contrast enhancement and remains in the body for a long period of time in comparison with ordinary Gd-DTPA 1. Although no selective accumulation in the tumor tissue was observed in these experiments, the present findings provide the promising result that the distribution of the boron carrier in the body can be followed in real time using MRI. We are now at the second stage to synthesize the compounds that can be accumulated into tumor as well as visualized by MRI for reliable estimation in the body.
Experimental
MR Imaging of Rat Tumor with Gd-Carborane Complex 2
The experiments were performed with four male tumor-bearing Donryu rats. Their age ranged from 4 to 6 weeks and their weights from 130 to 150 g. The tumors (AH109A-ascitic hepatoma) were implanted previously on the back, and allowed to grow for 2 weeks. This tumor line was established in the Institute of Development, Aging and Cancer, Tohoku University, and serially transplanted into these rats in ascitic form. Before each examination, the animals were anaesthetized with an intraperitoneal injection of 10 ml/kg of a 4% chloral hydrate solution. The MRI system of Gyroscan S 15 (Philips) with an 8 cm surface coil was used for this experiment. The scan parameters are as follows: spin echo sequence with TR time of 500 ms, TE time of 20 ms, 15 dynamic scan with a scan duration of 214 s, slice thickness of 3-5 mm.
Compound 2 (55 mg) was dissolved in NaHCO 3 aqueous solution (2: 0.05 M, NaHCO 3 : 0.13 M). The solution (0.3 ml) was injected intravenously through a catheter previously implemented in the jugular vein, at a dose of 0.1 mmol/kg body weight, and sagittal T 1 -weighted images were acquired following the protocol. A standard surface coil 8 cm in diameter was used for the images. To follow the excretion of compound 2, sagittal multisection T 1 -weighted images were obtained. A dynamic study was performed with 15 dynamic scans. The first scan was recorded manually, and then 14 scans were carried out during 53 min 45 s (214 s/each scan) after the injection of the compound. For the sake of comparison, normal Gd-DTPA 1 (Magnevist) was given to two rats at the same dose.
Gadolinium Concentrations in Various Tissues of Rats with GdCarborane Complex 2 Using ICP-AES Method
The distribution of the compound in vivo was examined using ICP-AES. This method is very useful to obtain the concentration of elements in tissues. The rats bearing tumor used in this experiment were the same as those used in MRI experiments. Compound 2 (227 mg) was dissolved in 10 ml of NaHCO 3 aqueous solution (finally, 2: 0.03 M, NaHCO 3 : 0.07 M). The pH value of this solution was 7.7. The solution (0.5 ml) was injected intravenously through the lateral tail vein at a dose of 0.1 mmol/kg body weight. Rats weighing 130-150 g (total number of rats was 9) were used for this experiment. To determine the con- centrations of gadolinium in the tissues, the rats were killed and blood, kidney, tumor, brain, and liver were removed at 5, 20, and 60 min after injection of the compound and dissolved in H 2 O 2 -HClO 4 (2/1) solution at 70°C for 3 h. The solution was filtered with a membrane filter (Millipore 0.22 mmf) and then the gadolinium concentration in the solution obtained was determined by ICP-AES.
Boron Distribution in the Body of Tumor-Bearing Rats Visualized by a a-Autoradiography The experiments were performed with two tumorbearing Donryu rats. The tumors (AH109A-ascitic hepatoma) were implanted previously on the back, and allowed to grow for 2 weeks. Compound 2 (0.1 mmol/kg body weight) was injected intravenously through the lateral tail vein. The rats were killed at 15 and 60 min after injection and frozen in a dry-ice acetone bath (Ϫ80°C). The frozen rats were coated with 4% of CMC (carboxymethyl cellulose) to make a block and frozen again at Ϫ80°C. Blocks were sliced in 40 mm thicknesses, and the slices obtained were dried at Ϫ80°C for two weeks and then placed in contact with the etching films (Baryotrack). The films were irradiated with a thermal neutron of the Kyoto University Reactor (a power of 5 MW, Cd ratio of 5000) with a total flueme of 1.6-1.9ϫ10 13 n/cm 2 and etched with KOH (30%) at 70°C for 3 h.
